{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:22:48Z","timestamp":1792873368509,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cbi.2019.108742","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T01:59:07Z","timestamp":1562637547000},"page":"108742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone"],"prefix":"10.1016","volume":"310","author":[{"given":"Oluwaseun A.","family":"Adeyanju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy O.","family":"Falodun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyesanmi A.","family":"Fabunmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Olatunji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodele O.","family":"Soladoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.108742_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.repbio.2013.09.007","article-title":"Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?","volume":"14","author":"van Houten","year":"2014","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.cbi.2019.108742_bib2","first-page":"298","article-title":"The effects of exercise on expression of CYP19 and StAR mRNA in steroid induced polycystic ovaries of female rats","volume":"11","author":"Aghaie","year":"2018","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.cbi.2019.108742_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ncpendmet0400","article-title":"The genetics of the polycystic ovary syndrome","volume":"3","author":"Urbanek","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol."},{"key":"10.1016\/j.cbi.2019.108742_bib4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/etm.2017.4642","article-title":"Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: aggravated complication of pregnancy","volume":"14","author":"Yao","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.cbi.2019.108742_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000351572","article-title":"Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome","volume":"22","author":"Alphan","year":"2013","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.cbi.2019.108742_bib6","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/jc.2014-1135","article-title":"Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome","volume":"99","author":"Glintborg","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/eurheartj\/ehl524","article-title":"The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns","volume":"28","author":"Wang","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2019.108742_bib8","article-title":"Blockade of mineralocorticoid receptor ameliorates oral contraceptive-induced insulin resistance by suppressing elevated uric acid and glycogen synthase kinase-3 instead of circulating mineralocorticoid","volume":"3","author":"Adeyanju","year":"2018","journal-title":"Arch Phyiol Biochem"},{"key":"10.1016\/j.cbi.2019.108742_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat- and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2019.108742_bib10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc09-1791","article-title":"Long-term metformin use is associated with decreased risk of breast cancer","volume":"33","author":"Bodmer","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2019.108742_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/CCO.0b013e32834e0582","article-title":"Metabolic diseases and cancer risk","volume":"24","author":"Faulds","year":"2012","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.cbi.2019.108742_bib12","first-page":"4420","article-title":"Effects of methyltestosterone on insulin secretion and sensitivity in women","volume":"83","author":"Diamond","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0015-0282(16)56633-3","article-title":"Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia","volume":"61","author":"Rajkhowa","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cbi.2019.108742_bib14","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","article-title":"Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization","volume":"17","author":"Sir-Petermann","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.cbi.2019.108742_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.cbi.2019.108742_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1055\/s-0030-1262855","article-title":"Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations","volume":"42","author":"Luque-Ramirez","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cbi.2019.108742_bib17","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, PPAR\u03b3 and pro-inflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2019.108742_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cbi.2019.108742_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1751-7176.2011.00511.x","article-title":"Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics","volume":"13","author":"Epstein","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.cbi.2019.108742_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108742_bib21","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","volume":"2","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cbi.2019.108742_bib22","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-10-0709","article-title":"Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome","volume":"164","author":"Studen","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108742_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/eje.0.1500351","article-title":"A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism","volume":"150","author":"Keletimur","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108742_bib25","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2013-1040","article-title":"Improved efficacy of low dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study","volume":"98","author":"Ganie","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1080\/14656566.2016.1215430","article-title":"Spironolactone in the treatment of polycystic ovary syndrome","author":"Armanini","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.cbi.2019.108742_bib27","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cbi.2019.108742_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/REP-15-0352","article-title":"Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment","volume":"151","author":"Daneasa","year":"2016","journal-title":"Reproduction"},{"key":"10.1016\/j.cbi.2019.108742_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali","year":"2004","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.cbi.2019.108742_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1993.tb01013.x","article-title":"Polycystic ovaries are a common finding in untreated female to male transsexuals","volume":"38","author":"Balen","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108742_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-0034-1371090","article-title":"Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions","volume":"32","author":"Maliqueo","year":"2014","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.cbi.2019.108742_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mce.2012.10.029","article-title":"Long term management of polycystic ovarian syndrome (PCOS)","volume":"373","author":"Bates","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108742_bib34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/09513590.2012.671394","article-title":"Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome \u2013 a retrospective analysis","volume":"28","author":"Kulshreshtha","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108742_bib35","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2010"},{"key":"10.1016\/j.cbi.2019.108742_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2016.10.033","article-title":"Altered expression of miRNAs in the uterus from a letrozole\u2010induced rat PCOS model","volume":"598","author":"Li","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2019.108742_bib37","first-page":"1","article-title":"Blockade of mineralocorticoid receptor ameliorates oral contraceptive-induced insulin resistance by suppressing elevated uric acid and glycogen synthase kinase-3 instead of circulating mineralocorticoid","author":"Adeyanju","year":"2018","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2019.108742_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mendia","year":"2008","journal-title":"Metab. Syndrome Relat. Disord."},{"key":"10.1016\/j.cbi.2019.108742_bib39","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1139\/cjpp-2017-0630","article-title":"Oral hormonal therapy with ethinylestradiol\u2013levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats","volume":"96","author":"Adeyanju","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108742_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/13510002.1996.11747079","article-title":"Glutathione metabolizing enzymes and oxidative stress in ferric nitrilotriacetate mediated hepatic injury","volume":"2","author":"Iqbal","year":"1996","journal-title":"Redox Rep."},{"key":"10.1016\/j.cbi.2019.108742_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2014.11.012","article-title":"Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study","volume":"136","author":"Gottschau","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cbi.2019.108742_bib43","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.115.131631","article-title":"A novel letrozole model recapitulates both the reproductive and metabolic phenotypes of polycystic ovary syndrome in female mice","volume":"93","author":"Kauffman","year":"2015","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cbi.2019.108742_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1642-431X(12)60089-8","article-title":"The ameliorative effects of Eurycoma longifolia Jack on testosterone-induced reproductive disorders in female rats","volume":"12","author":"Abdulghani","year":"2012","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.cbi.2019.108742_bib45","first-page":"309","article-title":"Antiandrogenic effect of Symplocos racemosa Roxb. against letrozole induced polycystic ovary using rat model","volume":"1","author":"Jadhav","year":"2013","journal-title":"J Coast Life Med"},{"key":"10.1016\/j.cbi.2019.108742_bib46","first-page":"99","article-title":"Effects of aqueous extract of Cnestis ferruginea (Vahl ex DC) root on the biochemical and clinical parameters of anastrozole-induced polycystic ovarian syndrome rat model","volume":"17","author":"Yakubu","year":"2013","journal-title":"J. Endocrinol. Reprod."},{"key":"10.1016\/j.cbi.2019.108742_bib47","series-title":"Principles and Practice of Obstetrics and Gynecology for Postgraduates","first-page":"676","author":"Desai","year":"2008"},{"key":"10.1016\/j.cbi.2019.108742_bib48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cbi.2019.108742_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108742_bib50","first-page":"1277","article-title":"Sex hormone-binding globulin during puberty in normal and hyperandrogenic girls","volume":"13","author":"Pugeat","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.cbi.2019.108742_bib52","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/HYPERTENSIONAHA.107.096925","article-title":"Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate","volume":"50","author":"Armanini","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2019.108742_bib53","first-page":"582","article-title":"Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib54","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"De Gasparo","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108742_bib55","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG (mRen2) 27 rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.cbi.2019.108742_bib56","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2012-3971","article-title":"Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired \u03b2-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study","volume":"98","author":"Bianchi","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib57","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2215\/CJN.03240410","article-title":"One-hour postload plasma glucose levels are associated with kidney dysfunction","volume":"5","author":"Succurro","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2019.108742_bib58","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1002\/jcp.27757","article-title":"Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: using either hemin or L\u2010arginine","volume":"234","author":"Ragy","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cbi.2019.108742_bib59","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.18203\/2320-1770.ijrcog20174029","article-title":"Role of luteinizing hormone LH and insulin resistance in polycystic ovarian syndrome","volume":"6","author":"Ambiger","year":"2017","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"10.1016\/j.cbi.2019.108742_bib60","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.18203\/2320-1770.ijrcog20175013","article-title":"Role of insulin sensitising agents in altering PSA level in PCOS","volume":"6","author":"Panigrahy","year":"2017","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"10.1016\/j.cbi.2019.108742_bib61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0015-0282(16)56633-3","article-title":"Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia","volume":"61","author":"Rajkhowa","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cbi.2019.108742_bib62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00404-017-4429-2","article-title":"Polycystic ovary syndrome, adipose tissue and metabolic syndrome","volume":"296","author":"Delitala","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.cbi.2019.108742_bib63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.cbi.2019.108742_bib64","first-page":"176","article-title":"Effect of grape seed extract on lipid profile and expression of interleukin\u20106 in polycystic ovarian syndrome Wistar rat model","volume":"11","author":"Salmabadi","year":"2017","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.cbi.2019.108742_bib65","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/jphp.12297","article-title":"Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats","volume":"66","author":"Pai","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108742_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1399-5448.2010.00710.x","article-title":"Cardiometabolic risk factors as apolipoprotein B, triglyceride\/HDLcholesterol ratio and C-reactive protein, in adolescents with and without obesity: cross-sectional study in middle class suburban children","volume":"12","author":"Musso","year":"2011","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cbi.2019.108742_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.med.51.1.149","article-title":"Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes","volume":"51","author":"Adams","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cbi.2019.108742_bib68","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jcem.83.8.5041","article-title":"The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome","volume":"83","author":"Diamanti-Kandarakis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.108742_bib69","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00721.2012","article-title":"Impact of glucose-6 phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease","volume":"304","author":"Hecker","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cbi.2019.108742_bib70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.fertnstert.2004.11.031","article-title":"Relationship between reactive oxygen species production and lipid peroxidation in human sperm suspensions and their association with sperm function","volume":"83","author":"Williams","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cbi.2019.108742_bib71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13048-017-0359-7","article-title":"Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats","volume":"10","author":"Ullah","year":"2017","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.cbi.2019.108742_bib72","doi-asserted-by":"crossref","first-page":"L699","DOI":"10.1152\/ajplung.1995.268.5.L699","article-title":"The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide","volume":"268","author":"Pryor","year":"1995","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.cbi.2019.108742_bib73","doi-asserted-by":"crossref","first-page":"H660","DOI":"10.1152\/ajpheart.1992.263.3.H660","article-title":"Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ","volume":"263","author":"Banerjee","year":"1992","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cbi.2019.108742_bib74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yjmcc.2006.05.023","article-title":"Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation","volume":"42","author":"Mount","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2019.108742_bib75","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioavailability, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2019.108742_bib76","first-page":"1","article-title":"Mineralocorticoid receptor blockade attenuates disrupted glutathione-dependent antioxidant defense and elevated endoglin in the hearts of pregnant rats exposed to testosterone","author":"Usman","year":"2019","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108742_bib77","first-page":"930","article-title":"Assessment of DNA damage in testes from young Wistar male rat treated with monosodium glutamate","volume":"9","author":"Ismail","year":"2012","journal-title":"Life Sci. J."},{"key":"10.1016\/j.cbi.2019.108742_bib78","first-page":"35","article-title":"Effects of monosodium glutamate and acrylamide on the liver tissue of adult Wistar rats","volume":"10","author":"AL-Mosaibih","year":"2013","journal-title":"Life Sci. J."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719305976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719305976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:56:45Z","timestamp":1757858205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719305976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":78,"alternative-id":["S0009279719305976"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108742","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108742"}}